4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
of SGLT2 inhibitors ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... #EBM #trial #visualabstract ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-converting enzyme inhibitor ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... ACCAHA #Algorithm #Management
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
release Diagnosis ... functional ID) Treatment ... mortality and CV ... deficiency #CHF #HFrEF ... #management #cardiology
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
heart function (JVD ... Bypass Other Treatment ... antagonist • BENEFiT Trial ... Phosphodiesterase inhibitor ... #management